Search
Beth Loe
National Co-ordinator
DHBNZ Safe and Quality Use of Medicines Group
Ph 09 580 9160
CONTACT US
FEED BACK
ACCESS KEYS
SITE MAP
Home
About SQM Group
Meetings
2011 Meetings
2010 Minutes
2009 Minutes
2008 Minutes
2007 Minutes
2006 Minutes
2005 Minutes
2004 Minutes
2003 Minutes
Terms of Reference
National Strategy
Annual Reports
Newsletters
2011
2010
2009
2008
2007
2006
2005
SQM Group Alerts and Publications
Abbreviations when prescribing medicines
Caffeine citrate oral solution
Colchicine
Colour coded wristbands
Dabigatran
Diltiazem
Heparin
Humalog insulin
Intravenous Infusion Practice
IT chemotherapy & IV vinca alkaloids
LMWH in Renal Impairment
Medicines Management
Morphine
Potassium Chloride Concentrated Injection
Warfarin
Position statement - barcoding
Position Statement - discharge summaries
Position Statement - Intraveous Infusion Practice
INNs and BANs
Current Projects
Morphine Alert
National Drug Chart
Medicines Reconciliation
Look-alike sound-alike medicines
Patient Information Leaflet
Medicines Safety in Renal Impairment
Oral Methotrexate - once weekly dosing
Transdermal patches
Prescribing by weight in children
Unfractionated heparin
Links
:
SQM Group Alerts and Publications
»
Dabigatran
::..
Alert 11 Dabigatran
Title
Owner
Category
Modified Date
Size (Kb)
Letter accompanying dabigatran alert
7/25/2011
212.51
Download
Dabigatran alert
7/25/2011
258.06
Download
Copyright 2007 by Safe use of Medicines
Disclaimer